Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Acromegaly is associated with increased cancer risk: a survey in Italy.
Terzolo M, Reimondo G, Berchialla P, Ferrante E, Malchiodi E, De Marinis L, Pivonello R, Grottoli S, Losa M, Cannavo S, Ferone D, Montini M, Bondanelli M, De Menis E, Martini C, Puxeddu E, Velardo A, Peri A, Faustini-Fustini M, Tita P, Pigliaru F, Peraga G, Borretta G, Scaroni C, Bazzoni N, Bianchi A, Berton A, Serban AL, Baldelli R, Fatti LM, Colao A, Arosio M; Italian Study Group of Acromegaly. Terzolo M, et al. Among authors: pigliaru f. Endocr Relat Cancer. 2017 Sep;24(9):495-504. doi: 10.1530/ERC-16-0553. Epub 2017 Jul 14. Endocr Relat Cancer. 2017. PMID: 28710115 Free article.
Efficacy and safety of 48 weeks of treatment with octreotide LAR in newly diagnosed acromegalic patients with macroadenomas: an open-label, multicenter, non-comparative study.
Grottoli S, Celleno R, Gasco V, Pivonello R, Caramella D, Barreca A, Ragazzoni F, Pigliaru F, Alberti D, Ferrara R, Angeletti G. Grottoli S, et al. Among authors: pigliaru f. J Endocrinol Invest. 2005 Dec;28(11):978-83. doi: 10.1007/BF03345335. J Endocrinol Invest. 2005. PMID: 16483175
Dopamine D2 receptor gene polymorphisms and response to cabergoline therapy in patients with prolactin-secreting pituitary adenomas.
Filopanti M, Barbieri AM, Angioni AR, Colao A, Gasco V, Grottoli S, Peri A, Baglioni S, Fustini MF, Pigliaru F, Monte PD, Borretta G, Ambrosi B, Jaffrain-Rea ML, Gasperi M, Brogioni S, Cannavò S, Mantovani G, Beck-Peccoz P, Lania A, Spada A. Filopanti M, et al. Among authors: pigliaru f. Pharmacogenomics J. 2008 Oct;8(5):357-63. doi: 10.1038/tpj.2008.1. Epub 2008 Mar 11. Pharmacogenomics J. 2008. PMID: 18332900
Glycometabolic control in acromegalic patients with diabetes: a study of the effects of different treatments for growth hormone excess and for hyperglycemia.
Cambuli VM, Galdiero M, Mastinu M, Pigliaru F, Auriemma RS, Ciresi A, Pivonello R, Amato M, Giordano C, Mariotti S, Colao A, Baroni MG. Cambuli VM, et al. Among authors: pigliaru f. J Endocrinol Invest. 2012 Feb;35(2):154-9. doi: 10.3275/7685. Epub 2011 Apr 28. J Endocrinol Invest. 2012. PMID: 21532330
Growth hormone receptor variants and response to pegvisomant in monotherapy or in combination with somatostatin analogs in acromegalic patients: a multicenter study.
Filopanti M, Olgiati L, Mantovani G, Corbetta S, Arosio M, Gasco V, De Marinis L, Martini C, Bogazzi F, Cannavò S, Colao A, Ferone D, Arnaldi G, Pigliaru F, Peri A, Angeletti G, Jaffrain-Rea ML, Lania AG, Spada A. Filopanti M, et al. Among authors: pigliaru f. J Clin Endocrinol Metab. 2012 Feb;97(2):E165-72. doi: 10.1210/jc.2011-1769. Epub 2011 Dec 7. J Clin Endocrinol Metab. 2012. PMID: 22162472 Clinical Trial.
Predictors of morbidity and mortality in acromegaly: an Italian survey.
Arosio M, Reimondo G, Malchiodi E, Berchialla P, Borraccino A, De Marinis L, Pivonello R, Grottoli S, Losa M, Cannavò S, Minuto F, Montini M, Bondanelli M, De Menis E, Martini C, Angeletti G, Velardo A, Peri A, Faustini-Fustini M, Tita P, Pigliaru F, Borretta G, Scaroni C, Bazzoni N, Bianchi A, Appetecchia M, Cavagnini F, Lombardi G, Ghigo E, Beck-Peccoz P, Colao A, Terzolo M; Italian Study Group of Acromegaly. Arosio M, et al. Among authors: pigliaru f. Eur J Endocrinol. 2012 Aug;167(2):189-98. doi: 10.1530/EJE-12-0084. Epub 2012 May 17. Eur J Endocrinol. 2012. PMID: 22596288 Free article.
Role of UGT1A1 and ADH gene polymorphisms in pegvisomant-induced liver toxicity in acromegalic patients.
Filopanti M, Barbieri AM, Mantovani G, Corbetta S, Gasco V, Ragonese M, Martini C, Bogazzi F, Colao A, Ferone D, Peri A, Pigliaru F, Angeletti G, Arosio M, Beck-Peccoz P, Lania AG, Spada A. Filopanti M, et al. Among authors: pigliaru f. Eur J Endocrinol. 2013 Dec 21;170(2):247-54. doi: 10.1530/EJE-13-0657. Print 2014 Feb. Eur J Endocrinol. 2013. PMID: 24217933
Disease control of acromegaly does not prevent excess mortality in the long term: results of a nationwide survey in Italy.
Arosio M, Sciannameo V, Contarino A, Berchialla P, Puglisi S, Pesatori AC, Ferrante E, Filopanti M, Pivonello R, Dassie F, Rochira V, Cannavò S, De Menis E, Pigliaru F, Grottoli S, Cambria V, Faustini-Fustini M, Montini M, Peri A, Ceccato F, Puxeddu E, Borretta G, Bondanelli M, Ferone D, Colao A, Terzolo M, Reimondo G. Arosio M, et al. Among authors: pigliaru f. J Endocrinol Invest. 2024 Jan 12. doi: 10.1007/s40618-023-02257-3. Online ahead of print. J Endocrinol Invest. 2024. PMID: 38214852 Free article.
23 results